跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 404 条关于
“mTNBC”
全部
404
临床试验
358
药物
8
机构
0
资讯
38
去年
mTNBC Pipeline Shows Promise with Novel Therapies in Clinical Trials
去年
ADC Safety Management in mTNBC: Genetic Screening and Prophylactic Strategies Emerge for Sacituzumab Govitecan
去年
FDA Clears Phase 2 Trial of Leronlimab for Microsatellite-Stable Colorectal Cancer
10个月前
TLX250-CDx Shows Promise in Triple Negative Breast Cancer as OPALESCENCE Trial Results Published
6个月前
Vienna's VALANX Biotech Secures €3 Million to Advance Precision ADC Platform for Triple-Negative Breast Cancer
去年
Blood Test Monitoring PD-L1 Expression Shows Promise for Improving Immunotherapy Outcomes in Metastatic Breast Cancer
去年
Meta-Analysis Confirms Sacituzumab Govitecan's Superior Efficacy in HR+/HER2- Metastatic Breast Cancer
去年
Trodelvy-Keytruda Combination Shows Promising Results in First-Line Treatment for Triple-Negative Breast Cancer
去年
Atezolizumab Fails to Improve Event-Free Survival in Triple-Negative Breast Cancer
去年
Tislelizumab Triplet Demonstrates Promising Results in Metastatic TNBC
第 1 页,共 4 页
上一页
下一页